MENU
ELDN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Eledon Pharmaceuticals (ELDN) Earnings Date & Reports

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company... Show more

A.I. Advisor
published Earnings

ELDN is expected to report earnings to rise 1.38% to -21 cents per share on March 19

Eledon Pharmaceuticals ELDN Stock Earnings Reports
Q4'25
Est.
$-0.21
Q3'25
Beat
by $0.03
Q2'25
Beat
by $0.09
Q1'25
Beat
by $0.17
Q4'24
Missed
by $0.32
The last earnings report on November 14 showed earnings per share of -20 cents, beating the estimate of -24 cents. With 927.57K shares outstanding, the current market capitalization sits at 119.30M.
View a ticker or compare two or three
ELDN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ELDN showed earnings on November 14, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer of pharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
19900 MacArthur Boulevard
Phone
+1 949 238-8090
Employees
20
Web
https://www.eledon.com